These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies]. Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440 [TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy. Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521 [TBL] [Abstract][Full Text] [Related]
5. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies. Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160 [TBL] [Abstract][Full Text] [Related]
6. Correlation of magnetic resonance imaging with histopathology in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). Tung K; Raman SV; King MA; Dephilip RM Clin Anat; 2006 Jan; 19(1):44-50. PubMed ID: 16258971 [TBL] [Abstract][Full Text] [Related]
7. Free-breathing high-spatial-resolution delayed contrast-enhanced three-dimensional viability MR imaging of the myocardium at 3.0 T: a feasibility study. Amano Y; Matsumura Y; Kumita S J Magn Reson Imaging; 2008 Dec; 28(6):1361-7. PubMed ID: 19025943 [TBL] [Abstract][Full Text] [Related]
8. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR). Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755 [TBL] [Abstract][Full Text] [Related]
9. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure. Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703 [TBL] [Abstract][Full Text] [Related]
10. [Cardiomyopathy and cardiac magnetic resonance]. Locca D; Jeanrenaud X; Schwitter J; Girod G; Monney P; De Palma R; Rizzo E; Prasad SK; Vogt P Rev Med Suisse; 2009 Oct; 5(221):2051-7. PubMed ID: 19911692 [TBL] [Abstract][Full Text] [Related]
11. Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease. Marcu CB; Nijveldt R; Beek AM; Van Rossum AC Heart Lung Circ; 2007 Apr; 16(2):70-8. PubMed ID: 17317312 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular magnetic resonance imaging: current applications and future directions. Desai MY; Lima JA; Bluemke DA Methods Enzymol; 2004; 386():122-48. PubMed ID: 15120249 [No Abstract] [Full Text] [Related]
13. The role of cardiovascular magnetic resonance in the diagnosis and management of cardiomyopathies. Masci PG; Dymarkowski S; Bogaert J J Cardiovasc Med (Hagerstown); 2008 May; 9(5):435-49. PubMed ID: 18403995 [TBL] [Abstract][Full Text] [Related]
14. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591 [TBL] [Abstract][Full Text] [Related]
15. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy. Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200 [TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease. Bucciarelli-Ducci C; Wu E; Lee DC; Holly TA; Klocke FJ; Bonow RO Curr Probl Cardiol; 2006 Feb; 31(2):128-68. PubMed ID: 16413381 [No Abstract] [Full Text] [Related]
17. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Kwong RY; Korlakunta H Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cardiac magnetic resonance imaging: Update 2010. Hombach V; Merkle N; Bernhard P; Rasche V; Rottbauer W Cardiol J; 2010; 17(6):549-57. PubMed ID: 21154256 [TBL] [Abstract][Full Text] [Related]
19. MRI in the assessment of non ischemic myocardial diseases. De Smet K; Verdries D; Tanaka K; De Mey J; De Maeseneer M Eur J Radiol; 2012 Jul; 81(7):1546-8. PubMed ID: 21392911 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen". Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV; Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]